JPH05213735A - Beautifully whitening cosmetic - Google Patents

Beautifully whitening cosmetic

Info

Publication number
JPH05213735A
JPH05213735A JP5437692A JP5437692A JPH05213735A JP H05213735 A JPH05213735 A JP H05213735A JP 5437692 A JP5437692 A JP 5437692A JP 5437692 A JP5437692 A JP 5437692A JP H05213735 A JPH05213735 A JP H05213735A
Authority
JP
Japan
Prior art keywords
skin
acid
pigmentation
whitening
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5437692A
Other languages
Japanese (ja)
Other versions
JP3170024B2 (en
Inventor
Tomoko Asai
智子 浅井
Mieko Nishida
美恵子 西田
Hidekazu Naeshiro
英一 苗代
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunstar Inc
Original Assignee
Sunstar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc filed Critical Sunstar Inc
Priority to JP05437692A priority Critical patent/JP3170024B2/en
Publication of JPH05213735A publication Critical patent/JPH05213735A/en
Application granted granted Critical
Publication of JP3170024B2 publication Critical patent/JP3170024B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To provide the beautifully whitening cosmetic exhibiting an excellent whitening effect, effective for lightening or preventing the blackening or chromatosis of skin caused by UV rays and further having an effect on suppressing affections such as inflammation against the skin by applying the cosmetic to the skin. CONSTITUTION:The beautifully whitening cosmetic comprises isoflavan and one or more kinds of the compounds selected from a 18-22C free fatty acid having two or more unsaturated bonds in the molecular structure, its salt, and its ester with a monohydric or dihydric alcohol.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は紫外線による皮膚の黒化
あるいはシミ、ソバカスなどの皮膚色素沈着の淡色化も
しくは予防に有効な美白化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a whitening cosmetic composition which is effective for darkening or preventing skin darkening due to ultraviolet rays or skin pigmentation such as spots and freckles.

【0002】[0002]

【従来の技術・発明が解決しようとする課題】皮膚に対
して日光からの紫外線が照射されると、皮膚内の色素細
胞に色素が生成し皮膚の黒化や皮膚色素の沈着によるシ
ミ、ソバカスが生じることが知られている。従来より、
このような皮膚の黒化の予防やシミ、ソバカスの除去を
目的として種々の美白化粧料が提案されている。たとえ
ば、ビタミンCおよびその誘導体、グルタチオン等の還
元剤、過酸化水素、胎盤エキス、コウジ酸等のメラニン
生成抑制物質を用いたものが知られている。
2. Description of the Related Art When the skin is irradiated with ultraviolet rays from the sun, pigments are formed in pigment cells in the skin, resulting in darkening of the skin and deposition of skin pigments and freckles. Is known to occur. Traditionally,
Various whitening cosmetics have been proposed for the purpose of preventing such blackening of the skin and removing spots and freckles. For example, it is known to use vitamin C and its derivatives, a reducing agent such as glutathione, hydrogen peroxide, a placenta extract, and a melanin production inhibitor such as kojic acid.

【0003】しかし、ビタミンC類は酸化され易く、そ
れを配合した化粧料の変色、変臭を招くという欠点があ
る。グルタチオン等の還元剤は、不快臭がある上に、経
皮吸収性にも問題があり、過酸化水素は、安全性や、安
定性の点で問題があるとされている。又、胎盤エキスの
ような動物組織抽出系のものはその効果が十分でなく、
また、その安定性や色、臭気等の点でも問題がある。ま
た、コウジ酸も少量では皮膚の黒化を防止する効果が小
さい等の問題があるので、美白化粧料の有効成分として
はいずれも充分なものとは言い難い。このように従来よ
り知られているこれらのメラニン生成抑制物質は、これ
らのみを用いても効果の点で不十分であったり、安全
性、安定性等の種々の面で実用可能なものはほとんどな
いのが実情である。
[0003] However, vitamin C has a drawback that it is easily oxidized and causes discoloration and odor of cosmetics containing it. It is said that reducing agents such as glutathione have an unpleasant odor and also have a problem of transdermal absorbability, and hydrogen peroxide has a problem of safety and stability. Moreover, the effect of animal tissue extraction system such as placenta extract is not sufficient,
There are also problems in terms of stability, color and odor. Also, since kojic acid has a problem that the effect of preventing blackening of the skin is small when it is in a small amount, it cannot be said that any of them is sufficient as an active ingredient of a whitening cosmetic composition. As described above, these conventionally known melanin production-inhibitory substances are insufficient in terms of effect even if they are used alone, and most of them are practical in various aspects such as safety and stability. The reality is that there is none.

【0004】一方、不飽和脂肪酸は、単独で効果が出る
に足る量を用いた場合、その安全性が懸念されている。
したがって、本発明の目的は、優れた美白効果を有する
と共に副作用がなく安全性の高い、前記の従来の問題点
を解決した美白化粧料を提供することにある。
On the other hand, when unsaturated fatty acids are used alone in an amount sufficient to exert their effects, there is concern about their safety.
Therefore, it is an object of the present invention to provide a whitening cosmetic composition which has an excellent whitening effect, has no side effects and is highly safe, and which solves the above conventional problems.

【0005】また、イソフラバン類については、グラブ
リジンの美白作用が知られており(特開昭1ー3110
11号、フレグランスジャーナル111,59−66
(1990))、またヒスパグラブリジンA、ヒスパグ
ラブリジンBについては抗菌活性が知られている(He
terocycles9(11),1533−1538
(1978))が、メラニン産生抑制に関する報告は見
られなかった。従って、本発明の目的は、優れた美白効
果を有すると共に副作用がなく安全性の高い、前記従来
の問題点を解決した美白化粧料を提供することにある。
With respect to isoflavans, the whitening effect of glabridin is known (Japanese Patent Laid-Open No. 1-3110).
No. 11, Fragrance Journal 111, 59-66
(1990)), and antibacterial activity is known for hispaglabridin A and hispaglabrizin B (He).
thermocycles9 (11), 1533-1538
(1978)), but no report on suppression of melanin production was found. Therefore, it is an object of the present invention to provide a whitening cosmetic composition which has an excellent whitening effect, has no side effects and is highly safe, and which solves the above conventional problems.

【0006】[0006]

【課題を解決するための手段】本発明は、イソフラバン
類および炭素数18〜22かつ分子構造中の不飽和結合
数が2以上の遊離脂肪酸、その塩、あるいは一価又は二
価アルコールとのエステルよりなる群れから選ばれる1
種又は2種以上の成分を配合することにより、皮膚の色
素沈着の淡色化、もしくは予防効果に優れた相乗効果の
現われることを見い出し、本発明を完成するに至った。
The present invention is directed to isoflavans and free fatty acids having 18 to 22 carbon atoms and 2 or more unsaturated bonds in the molecular structure, salts thereof, or esters with monohydric or dihydric alcohols. 1 selected from a group of
The present invention has been completed by discovering that by blending two or more components, a pigmentation of the skin is lightened or a synergistic effect with an excellent preventive effect appears.

【0007】すなわち本発明の要旨は、(a)イソフラ
バン類、(b)炭素数18〜22かつ分子構造中の不飽
和結合数が2以上の遊離脂肪酸、その塩、あるいは一価
又は二価アルコールとのエステルより選ばれた1種又は
2種以上の成分を配合したことを特徴とする美白化粧料
に関する。
That is, the gist of the present invention is (a) isoflavans, (b) free fatty acid having 18 to 22 carbon atoms and 2 or more unsaturated bonds in the molecular structure, a salt thereof, or a monohydric or dihydric alcohol. The present invention relates to a whitening cosmetic composition containing one or more components selected from the ester of

【0008】本発明で用いられる(a)成分であるイソ
フラバン類とは、甘草等の植物からの抽出品、または合
成品のいずれでもよく、イソフラバン類に属するものな
ら種類を問わないが、特にヒスパグラブリジンA、ヒス
パグラブリジンB、グラブリジン、ファセオリンイソフ
ラバンが好ましい。
The component (a) used in the present invention, isoflavans, may be either an extract from a plant such as licorice or a synthetic product, and any type may be used as long as it belongs to the isoflavans. Grabridine A, hispaglabridine B, glablysin and phaseolin isoflavan are preferred.

【0009】本発明で用いられるイソフラバン類の美白
化粧料への配合量は、化粧料の種類、期待される色白効
果の程度によっても異なるが、通常0.005%〜1重
量%の範囲である。好ましくは、0.01〜0.5重量
%の範囲である。配合量が0.005重量%より少ない
と、効果が充分でなく、また、1重量%を超えて配合し
ても、その量に見合うだけの効果が期待できないので、
1重量%程度の配合量で充分である。
The amount of the isoflavans used in the present invention in the whitening cosmetic composition is usually 0.005% to 1% by weight, although it varies depending on the kind of the cosmetic composition and the expected degree of the whitening effect. .. It is preferably in the range of 0.01 to 0.5% by weight. If the compounding amount is less than 0.005% by weight, the effect is not sufficient, and even if the compounding amount exceeds 1% by weight, the effect commensurate with the amount cannot be expected.
A blending amount of about 1% by weight is sufficient.

【0010】本発明で用いられる(b)成分としては、
例えば、リノール酸、リノエライジン酸、α−リノレン
酸、γ−リノレン酸、ジホモ−γ−リノレン酸、アラキ
ドン酸、エイコサペンタエン酸等が挙げられ、また、こ
れら遊離脂肪酸の塩としては、ナトリウム塩、カリウム
塩などの金属塩、アルギニン塩、リジン塩などのアミノ
酸塩、トリエタノールアミン塩、モノエタノールアミン
塩等のアミン塩などが挙げられ、さらに、これら遊離脂
肪酸のエステルとしては、メタノール、エタノール、イ
ソプロピルアルコールなどの一価アルコールのエステ
ル、エチレングリコール、プロピレングリコール、1,
3−ブチレングリコールなどの二価のアルコールとのエ
ステルなどが挙げられ、これらの成分の中から1種また
は2種以上の成分が用いられる。
As the component (b) used in the present invention,
For example, linoleic acid, linoelaidic acid, α-linolenic acid, γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, eicosapentaenoic acid and the like, and as the salts of these free fatty acids, sodium salts, Examples thereof include metal salts such as potassium salts, amino acid salts such as arginine salts and lysine salts, amine salts such as triethanolamine salts and monoethanolamine salts, and the esters of these free fatty acids include methanol, ethanol and isopropyl. Esters of monohydric alcohols such as alcohol, ethylene glycol, propylene glycol, 1,
Examples thereof include esters with dihydric alcohols such as 3-butylene glycol, and one or more components are used from these components.

【0011】本発明においては、これらの活性成分と前
記の(a)成分であるイソフラバン類とを併用すること
により、皮膚に対し、相乗的な美白効果を示す。このよ
うな(b)成分の化粧料中における配合量は、通常0.
1〜10%である。好ましくは1.0〜5.0重量%で
ある。配合量が0.1重量%より少ないと色素沈着の淡
色化効果が充分でなく、また、10重量%を超えて配合
すると、皮膚に対して刺激性を示すようになる。
In the present invention, by using these active ingredients in combination with the above-mentioned component (a), isoflavans, a synergistic whitening effect on the skin is exhibited. The blending amount of such a component (b) in the cosmetic is usually 0.
It is 1 to 10%. It is preferably 1.0 to 5.0% by weight. If the blending amount is less than 0.1% by weight, the lightening effect of pigmentation is not sufficient, and if the blending amount exceeds 10% by weight, it becomes irritating to the skin.

【0012】このような本発明の美白化粧料は、前記の
ような(a)、(b)成分を配合することに特徴を有す
るものであるが、本発明の美白化粧料にはこれらの成分
の他にも、通常美白化粧料に配合される基剤や種々の添
加剤を配合してもよい。例えば、油分、界面活性剤、香
料および防腐剤等が適宜配合される。
The whitening cosmetic composition of the present invention is characterized by blending the components (a) and (b) as described above, but the whitening cosmetic composition of the present invention contains these components. In addition to the above, bases and various additives that are usually added to whitening cosmetics may be added. For example, oils, surfactants, fragrances, preservatives and the like are appropriately added.

【0013】本発明の美白化粧料の調製は、常法によ
り、化粧水、化粧油、クリーム、乳液、パック、パウダ
ー等とすることができる。
The whitening cosmetic composition of the present invention can be prepared into a lotion, a cosmetic oil, a cream, an emulsion, a pack, a powder and the like by a conventional method.

【0014】以下、実施例および試験例により本発明を
さらに詳しく説明する。
The present invention will be described in more detail below with reference to examples and test examples.

【実施例】【Example】

実施例1 化粧水の調製:精製水に所定量のグリセリン、クエン
酸、クエン酸ナトリウムを溶解する。別個にエタノール
に所定量のリノール酸、α−リノレン酸、ヒスパグラブ
リジンA、ポリオキシエチレン硬化ヒマシ油(60E.
O.)、香料を溶解し、前記の精製水溶液に加えて可溶
化し、瀘過して、化粧水を得た。 〔成 分〕 〔配合量(重量%)〕 ヒスパグラブリジンA 0.05 リノール酸 1.0 α−リノレン酸 1.0 グリセリン 6.0 エタノール 9.0 ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.8 パラオキシ安息香酸メチル 0.05 クエン酸 0.05 クエン酸ナトリウム 0.07 香料 0.1 水溶性プラセンタエキス 2.0 精製水 残部
Example 1 Preparation of lotion: Predetermined amounts of glycerin, citric acid and sodium citrate are dissolved in purified water. Separately from ethanol, a predetermined amount of linoleic acid, α-linolenic acid, hispaglabridine A, polyoxyethylene hydrogenated castor oil (60E.
O. ), The fragrance was dissolved, added to the purified aqueous solution to solubilize it, and filtered to obtain a lotion. [Components] [Blending amount (% by weight)] Hispaglabridin A 0.05 Linoleic acid 1.0 α-Linolenic acid 1.0 Glycerin 6.0 Ethanol 9.0 Polyoxyethylene hydrogenated castor oil (60 EO) 0.8 Methyl paraoxybenzoate 0.05 Citric acid 0.05 Sodium citrate 0.07 Perfume 0.1 Water-soluble placenta extract 2.0 Purified water balance

【0015】実施例2 化粧用油の調製:スクワランに下記の他の成分を所定
量、下記の重量%となるように均一に溶解して、化粧用
油を得た。 〔成 分〕 〔配合量(重量%)〕 ヒスパグラブリジンB 0.05 リノール酸エチル 1.0 γ−リノレン酸 1.0 パルミチン酸アスコルビル 0.2 酢酸レチノール 0.3 スクワラン 残部
Example 2 Preparation of Cosmetic Oil: A cosmetic oil was obtained by uniformly dissolving the following other components in squalane in a predetermined amount so as to be the following weight%. [Components] [Compounding amount (wt%)] Hispaglabridine B 0.05 Ethyl linoleate 1.0 γ-Linolenic acid 1.0 Ascorbyl palmitate 0.2 Retinol acetate 0.3 Squalane balance

【0016】実施例3 クリームの調製:下記の成分のうち、成分(A)を所定
量、下記の重量%なるように混合後、加熱溶解し、80
℃に保持した。これとは別に、香料を除いた成分(B)
を所定量、下記の重量%となるように混合後、加熱溶解
して80℃に保持した。前記の香料を除いた成分(B)
の混合物に前記成分(A)の混合物を攪拌しながら加
え、充分混合し、その後、攪拌しながら40℃程度まで
冷却を行なってから香料を加えた。これを、さらに冷却
して下記の成分からなるクリームを得た。 〔成 分〕 〔配合量(重量%)〕 成分(A) ファセオリンイソフラバン 0.1 γ−リノレン酸 2.0 エイコサペンタエン酸 1.0 サラシミツロウ 4.0 セタノール 2.0 ミリスチン酸イソプロピル 5.0 ラノリン 2.0 流動パラフィン 9.0 自己乳化型モノステアリン酸グリセリル 3.0 モノステアリン酸ポリオキシ エチレンソルビタン(20E.O.) 1.5 パラオキシ安息香酸プロピル 0.1 成分(B) パラオキシ安息香酸メチル 0.2 プロピレングリコール 5.0 香料 0.2 精製水 残部
Example 3 Preparation of cream: Of the following components, the component (A) was mixed in a predetermined amount so that the weight percentage was as follows, and the mixture was heated and dissolved.
Hold at 0 ° C. Separately from this, the component excluding the fragrance (B)
Was mixed in a predetermined amount so as to be the following weight%, heated and dissolved, and kept at 80 ° C. Ingredient (B) excluding the above fragrances
The mixture of the above-mentioned component (A) was added to the above mixture with stirring, mixed well, and then cooled to about 40 ° C. with stirring, and then the fragrance was added. This was further cooled to obtain a cream consisting of the following ingredients. [Components] [Blended amount (wt%)] Component (A) Phaseolin isoflavan 0.1 γ-linolenic acid 2.0 eicosapentaenoic acid 1.0 salami beeswax 4.0 cetanol 2.0 isopropyl myristate 5 0.0 Lanolin 2.0 Liquid paraffin 9.0 Self-emulsifying glyceryl monostearate 3.0 Polyoxy monostearate Ethylene sorbitan (20EO) 1.5 Propyl paraoxybenzoate 0.1 Component (B) Paraoxybenzoic acid Methyl 0.2 Propylene glycol 5.0 Perfume 0.2 Purified water Balance

【0017】実施例4 乳液の調製:下記の成分のうち、成分(A)を所定量、
下記の重量%なるように混合後、加熱溶解し、80℃に
保持した。これとは別に、香料を除いた成分(B)を所
定量、下記の重量%となるように混合後、加熱溶解して
80℃に保持した。前記の香料を除いた成分(B)の混
合物に前記成分(A)の混合物を攪拌しながら加え、充
分混合し、その後、攪拌しながら40℃程度まで冷却を
行なってから香料を加えた。これを、さらに冷却して下
記の成分からなる乳液を得た。 〔成 分〕 〔配合量(重量%)〕 成分(A) 1.0 リノエライジン酸 0.05 グラブリジン 2.0 リノール酸イソプロピル 5.0 流動パラフィン 2.0 ワセリン 2.0 ミツロウ 1.0 セスキオレイン酸ソルビタン 2.0 成分(B) イプシロンアミノカプロン酸 0.2 ポリオキシエチレンオレイル エーテル(20E.O.) 2.5 パラオキシ安息香酸エチル 0.2 プロピレングリコール 5.0 カルボキシビニルポリマー 0.5 水酸化カリウム 0.5 香料 0.2 精製水 残部
Example 4 Preparation of Emulsion: Of the following components, a predetermined amount of component (A),
After mixing so as to have the following weight%, the mixture was heated and dissolved, and kept at 80 ° C. Separately from this, a predetermined amount of the component (B) excluding the fragrance was mixed so as to have the following weight%, and the mixture was heated and melted and kept at 80 ° C. The mixture of the component (A) was added to the mixture of the component (B) excluding the above-mentioned fragrance with stirring, mixed well, and then cooled to about 40 ° C. with stirring, and then the fragrance was added. This was further cooled to obtain an emulsion containing the following components. [Components] [Blending amount (% by weight)] Component (A) 1.0 Linoelaidic acid 0.05 Glabridine 2.0 Isopropyl linoleate 5.0 Liquid paraffin 2.0 Vaseline 2.0 Beeswax 1.0 Sesquiolein Acid sorbitan 2.0 Component (B) Epsilon aminocaproic acid 0.2 Polyoxyethylene oleyl ether (20EO) 2.5 Ethyl paraoxybenzoate 0.2 Propylene glycol 5.0 Carboxyvinyl polymer 0.5 Potassium hydroxide 0.5 Perfume 0.2 Purified water balance

【0018】実施例5 パックの調製:α−リノレン酸、ヒスパグラブリジン
A、ドコサヘキサエン酸、香料およびエタノールを均一
に溶解する。これを酢酸ビニル・スチレン共重合体、ポ
リビニルアルコール、ソルビット、およびカオリンを均
一に混和したものに加える。これにさらに水溶性プラセ
ンタエキス、パラオキシ安息香酸エチルを精製水に均一
に溶解した溶液を加え、均一に混和し、パックを得た。 〔成 分〕 〔配合量(重量%)〕 α−リノレン酸 3.0 ヒスパグラブリジンA 0.05 ドコサヘキサエン酸 0.5 酢酸ビニル・スチレン共重合体 10.0 ポリビニルアルコール 10.0 ソルビット 5.0 カオリン 7.0 エタノール 5.0 香料 2.0 パラオキシ安息香酸エチル 0.2 精製水 残部
Example 5 Preparation of pack: α-linolenic acid, hispaglabridin A, docosahexaenoic acid, perfume and ethanol are uniformly dissolved. This is added to a homogenous blend of vinyl acetate-styrene copolymer, polyvinyl alcohol, sorbit, and kaolin. A solution in which the water-soluble placenta extract and ethyl paraoxybenzoate were uniformly dissolved in purified water was added to this, and the mixture was uniformly mixed to obtain a pack. [Components] [Blending amount (% by weight)] α-linolenic acid 3.0 Hispaglabridin A 0.05 docosahexaenoic acid 0.5 Vinyl acetate / styrene copolymer 10.0 Polyvinyl alcohol 10.0 Solbit 5.0 Kaolin 7.0 Ethanol 5.0 Fragrance 2.0 Ethyl paraoxybenzoate 0.2 Purified water Remainder

【0019】実施例6 パウダーの調製:ヒスパグラブリジンB、リノエライジ
ン酸、およびリノール酸エチルを加熱溶解し、70℃に
保持し、これをデキストリンおよびタルクの混合物に攪
拌しながら徐々に加えてパウダーを得た。 〔成 分〕 〔配合量(重量%)〕 ヒスパグラブリジンB 0.05 リノエライジン酸 2.0 リノール酸エチル 2.0 デキストリン 2.0 タルク 92.95 ステアリン酸デカグリセリル 1.0 試験例1 English 系茶色モルモットの背部を剃毛して紫外線(UV
B 強度 ; 0.8J/cm2)を照射した。この操作を3日間繰
返し、1週間後に色素沈着を得た。つぎに、この部位に
イソフラバン類、あるいは他の成分をエタノールに溶解
した検体を塗布量10μl/cm2で4週間累積塗布した。
色素沈着の淡色化を評価する方法として検体を塗布して
いない部位(無塗布)の色素沈着を0とし、その淡色化
の度合により、以下に示す判定基準に従い色素沈着度を
肉眼判定し、その結果を表1に示した。なお、効果の判
定基準は以下の通りである。 0;色素沈着は認められない 1;わずかに色素沈着の淡色化が認められる 2;中等度の色素沈着の淡色化が認められる 3;強度の色素沈着の淡色化が認められる
Example 6 Preparation of powder: Hispagrabrizin B, linoelaidic acid and ethyl linoleate were melted by heating and kept at 70 ° C., which was gradually added to a mixture of dextrin and talc with stirring to give powder. Obtained. [Components] [Amount (wt%)] Hispaglabridin B 0.05 Linoelaidic acid 2.0 Ethyl linoleate 2.0 Dextrin 2.0 Talc 92.95 Decaglyceryl stearate 1.0 Test Example 1 English system The back of a brown guinea pig is shaved and UV rays (UV
B intensity; 0.8 J / cm 2 ) was irradiated. This operation was repeated for 3 days, and pigmentation was obtained after 1 week. Next, a sample prepared by dissolving isoflavans or other components in ethanol was cumulatively applied to this site at an application amount of 10 μl / cm 2 for 4 weeks.
As a method of evaluating the lightening of pigmentation, the pigmentation of the site not coated with the sample (non-application) is set to 0, and the degree of the lightening determines the degree of pigmentation with the naked eye according to the criteria shown below. The results are shown in Table 1. The criteria for determining the effect are as follows. 0: No pigmentation is observed 1; Slight pigmentation lightening is observed 2; Moderate pigmentation lightening is observed 3; Intense pigmentation lightening is observed

【0020】[0020]

【表1】 [Table 1]

【0021】[0021]

【表2】 [Table 2]

【0022】表1および表2より明らかなごとく、イソ
フラバン類の活性成分単独でも、色素沈着の抑制または
淡色化が認められるが、これらに対して、リノール酸な
どの成分を併用した場合はさらに顕著な色素沈着の抑
制、または淡色化が認められた。
As is clear from Tables 1 and 2, suppression of pigmentation or lightening is observed even with the active ingredient of isoflavans alone, but it is more remarkable when combined with a component such as linoleic acid. Inhibition of various pigmentation or lightening was observed.

【0023】試験例2 20〜40歳代の健常人16人(男性8人、女性8人)
の上腕内側部の隣接4部位に1.0mW/cm2のUVを1.
1〜1.2MED(Minimal Erytherma Doses)相当の
紫外線を、3日間にわたって照射し、均一な色素沈着を
得た。その間、各部位に実施例3の配合成分のうちファ
セオリンイソフラバンを配合していないクリーム(クリ
ームAと略す)、同様にγ−リノレン酸、エイコサペン
タエン酸を配合していないクリーム(クリームBと略
す)、実施例3の配合成分からなるクリーム(クリーム
Cと略す)、及び実施例3の配合成分のうちファセオリ
ンイソフラバン、γ−リノレン酸、及びエイコサペンタ
エン酸のいずれも配合していないクリーム(クリームD
と略す)、を1日3回、4週間にわたり塗布した。塗布
量は、0.5mg/cm2とした。塗布開始から1月後に各ク
リームA、B、C塗布部の色素沈着度をクリームD塗布
部の色素沈着度と比較し、表3の結果を得た。
Test Example 2 16 healthy people in their 20s to 40s (8 men and 8 women)
UV of 1.0 mW / cm 2 was applied to the 4 adjacent parts of the inner part of the upper arm.
Ultraviolet rays corresponding to 1 to 1.2 MED (Minimal Erytherma Doses) were irradiated for 3 days to obtain uniform pigmentation. Meanwhile, a cream containing no phaseoline isoflavan among the ingredients of Example 3 in each part (abbreviated as cream A), and a cream containing no γ-linolenic acid or eicosapentaenoic acid (cream B) in the same manner. Abbreviated), and a cream comprising the compounding ingredients of Example 3 (abbreviated as Cream C), and among the compounding ingredients of Example 3, any of phaseolin isoflavan, γ-linolenic acid, and eicosapentaenoic acid. No cream (cream D
Abbreviated) was applied three times a day for 4 weeks. The coating amount was 0.5 mg / cm 2 . One month after the start of application, the degree of pigmentation of each cream A, B, and C application portion was compared with the degree of pigmentation of cream D application portion, and the results in Table 3 were obtained.

【0024】[0024]

【表3】 [Table 3]

【0025】表3より明らかなごとくイソフラバン類の
みを配合した場合(クリームA)および不飽和脂肪酸類
のみを配合した場合(クリームB)には、顕著な色素沈
着の淡色化作用は見られなかった。一方、イソフラバン
類および不飽和脂肪酸類を併用した場合(クリームC)
では顕著な色素沈着の淡色化が認められた。
As is clear from Table 3, when the isoflavans alone were blended (cream A) and the unsaturated fatty acids alone were blended (cream B), no noticeable lightening effect of pigmentation was observed. .. On the other hand, when isoflavans and unsaturated fatty acids are used together (cream C)
A remarkable lightening of pigmentation was observed in.

【0026】[0026]

【発明の効果】本発明の化粧料は、皮膚に適用すること
により、紫外線による皮膚の黒化あるいは色素沈着を消
失、淡色化もしくは予防し、優れた美白効果を発揮する
ものである。
By applying the cosmetic composition of the present invention to the skin, the skin blackening or pigmentation caused by ultraviolet rays disappears, becomes lighter in color or is prevented, and exhibits an excellent whitening effect.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 (a)イソフラバン類、(b)炭素数1
8〜22かつ分子構造中の不飽和結合数が2以上の遊離
脂肪酸、その塩、あるいは一価又は二価アルコールとの
エステルより選ばれた1種又は2種以上の成分を配合し
たことを特徴とする美白化粧料。
1. (a) Isoflavans, (b) carbon number 1
Characterized by blending one or more components selected from free fatty acids having 8 to 22 and two or more unsaturated bonds in the molecular structure, salts thereof, or esters with monohydric or dihydric alcohols. And whitening cosmetics.
【請求項2】 イソフラバン類が、ヒスパグラブリジン
A、ヒスパグラブリジンB、グラブリジン、及びファセ
オリンイソフラバンである特許請求の範囲第1項記載の
美白化粧料。
2. The whitening cosmetic composition according to claim 1, wherein the isoflavans are Hispaglabridine A, Hispaglabridine B, Glabridin, and Phaseolin phosphorus.
JP05437692A 1992-02-03 1992-02-03 Whitening cosmetics Expired - Lifetime JP3170024B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP05437692A JP3170024B2 (en) 1992-02-03 1992-02-03 Whitening cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP05437692A JP3170024B2 (en) 1992-02-03 1992-02-03 Whitening cosmetics

Publications (2)

Publication Number Publication Date
JPH05213735A true JPH05213735A (en) 1993-08-24
JP3170024B2 JP3170024B2 (en) 2001-05-28

Family

ID=12968961

Family Applications (1)

Application Number Title Priority Date Filing Date
JP05437692A Expired - Lifetime JP3170024B2 (en) 1992-02-03 1992-02-03 Whitening cosmetics

Country Status (1)

Country Link
JP (1) JP3170024B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08134026A (en) * 1994-10-20 1996-05-28 Prospa Bv Salt of aminoalcohol and medicinal prescription containing same
WO2001008652A1 (en) * 1999-07-30 2001-02-08 Unilever Plc Skin care composition
EP2303010A1 (en) * 2008-07-31 2011-04-06 Arch Personal Care Products, L.P. A composition for improving skin condition and appearance
JP2014505687A (en) * 2011-01-07 2014-03-06 アラーガン、インコーポレイテッド Melanin modified composition and method of use
JP2015527389A (en) * 2012-09-06 2015-09-17 ディグニティ サイエンシス リミテッド Cosmetic composition comprising EPA and GLA, and method for producing and using the same

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08134026A (en) * 1994-10-20 1996-05-28 Prospa Bv Salt of aminoalcohol and medicinal prescription containing same
WO2001008652A1 (en) * 1999-07-30 2001-02-08 Unilever Plc Skin care composition
JP2003505492A (en) * 1999-07-30 2003-02-12 ユニリーバー・ナームローゼ・ベンノートシヤープ Skin care composition
EP2303010A1 (en) * 2008-07-31 2011-04-06 Arch Personal Care Products, L.P. A composition for improving skin condition and appearance
EP2303010A4 (en) * 2008-07-31 2014-12-17 Arch Personal Care Products Lp A composition for improving skin condition and appearance
US9000033B2 (en) 2008-07-31 2015-04-07 Arch Personal Care Products, L.P. Composition for improving skin condition and appearance
JP2014505687A (en) * 2011-01-07 2014-03-06 アラーガン、インコーポレイテッド Melanin modified composition and method of use
JP2017101058A (en) * 2011-01-07 2017-06-08 アラーガン、インコーポレイテッドAllergan,Incorporated Melanin modification compositions and methods of use
JP2019112422A (en) * 2011-01-07 2019-07-11 アラーガン、インコーポレイテッドAllergan,Incorporated Melanin modification compositions and methods of use
JP2015527389A (en) * 2012-09-06 2015-09-17 ディグニティ サイエンシス リミテッド Cosmetic composition comprising EPA and GLA, and method for producing and using the same
CN109157428A (en) * 2012-09-06 2019-01-08 Af免疫有限公司 Cosmetic composition and production and preparation method thereof including eicosapentaenoic acid free acid and gamma-Linolenic acid free acid

Also Published As

Publication number Publication date
JP3170024B2 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
JP2614474B2 (en) Whitening cosmetics
JP3638832B2 (en) Cosmetic and / or dermatological composition comprising at least one mulberry extract, at least one seaweed extract and at least one salicylic acid derivative
JP4564471B2 (en) Composition suitable for external use
JP2608745B2 (en) Whitening cosmetics
JPS63284109A (en) Beautifying cosmetic
JPH05186324A (en) Beautifying cosmetic
JP2005120023A (en) Skin care preparation
JPH11286423A (en) Composition for suppressing body odor
JPH05271046A (en) Dermal medicine for external use
JPH0881325A (en) Cosmetic
JP3170024B2 (en) Whitening cosmetics
JP2676049B2 (en) Skin cosmetics
JP2665976B2 (en) Cosmetics
JP2552298B2 (en) Beautiful skin cosmetics
JPH0193520A (en) Beautifying and whitening cosmetic
JPH10158148A (en) Skin-whitening cosmetic
TW201244747A (en) Composition containing polyunsaturated fatty acid
JPH05201847A (en) Skin-beautifying cosmetic
JPH05194176A (en) Skin-beautifying cosmetic
JPH02207013A (en) Beautifying and whitening cosmetic
JP3258801B2 (en) Skin metabolism promoter
JPH03261705A (en) Melanin production-inhibitory external agent
JPH0818963B2 (en) Whitening cosmetics
JP2644353B2 (en) Whitening cosmetics
JP2628328B2 (en) Whitening cosmetics

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 19991116

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20010306

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080316

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090316

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090316

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100316

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100316

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110316

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120316

Year of fee payment: 11

EXPY Cancellation because of completion of term